The European Food Safety Authority (Efsa) has denied that it is waiting for the outcome of research on the safety of CBD by its US counterpart, the Food and Drug Administration (FDA), before it lets validated candidates complete the novel food application process.

Efsa denied claims by one of the validated applicants in the process, which said the agency had advised it not to proceed with the toxicological studies it had required CBD firms to produce until the FDA published its own safety data.

Read full article
I'm already a subscriber

Tiziana Cauli

Senior reporter
Tiziana is an Italian journalist from Sardinia. She has worked for both international and local media in Italy, South Africa, France, Spain, the UK, Lebanon and Belgium. She also worked as a communications manager for several international NGOs in the humanitarian sector.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization